Abstract:Synthesized by a simple method, Co nanosheets (NSs) are equipped with multiple enzyme‐like and broad‐spectrum reactive oxygen species (ROS) scavenging properties. Owing to the ability of fg and oligomerization inhibiting, Co NSs block the assembly and activation of NLRP3 inflammasome, thereby exhibiting NLRP3 inflammasome inhibition and anti‐inflammation effect in both systemic inflammation and colitis mouse models. Nucleotide‐binding domain and leucine rich repeat family pyrin domain containing 3 (NLRP3) inflammasomes are implicated in diverse inflammatory diseases, so their activation needs to be tightly controlled. Over generation of reactive oxygen species (ROS) is a key factor in NLRP3 inflammasome activation. Consequently, nanozymes with ROS scavenging ability are potential inhibitors of NLRP3 activation and promising therapeutic agents for related inflammatory diseases. Herein, a type of 2D cobalt hydroxide oxide nanosheets (Co NSs), a nanozyme with excellent multienzyme‐like activity, possessing peroxidase (POD), catalase (CAT), and superoxide dismutase (SOD) activities, exhibits superior ROS scavenging properties and protects cells from oxidative damage. Density functional theory (DFT) calculations further reveal these enzyme‐like catalytic reactions of ROS eliminating are spontaneous and CAT is dominant under physiological conditions. Performing multienzyme properties, Co NSs present excellent anti‐inflammation activity by blocking NLRP3 oligomerization and ASC speck formation, thereby inhibiting NLRP3 inflammasome assembly and activation. Importantly, treatment with Co NSs attenuates the severity of LPS‐induced systemic inflammation and DSS‐induced colitis. This study highlights a successful strategy for utilizing cobalt‐based nanozymes to scavenge ROS and provides valuable insights into the underlying mechanism, demonstrating the potential therapeutic effects of nanozyme for the prevention and treatment of NLRP3‐associatied inflammatory diseases.

2D Cobalt Oxyhydroxide Nanozymes Inhibit Inflammation by Targeting the NLRP3 Inflammasome (Adv. Funct. Mater. 27/2023)

2D Cobalt Oxyhydroxide Nanozymes Inhibit Inflammation by Targeting the NLRP3 Inflammasome

Construction of pH‐Dependent Nanozymes with Oxygen Vacancies as the High‐Efficient Reactive Oxygen Species Scavenger for Oral‐Administrated Anti‐Inflammatory Therapy

Nickle-cobalt alloy nanocrystals inhibit activation of inflammasomes

Oral pyroptosis nanoinhibitor for the treatment of inflammatory bowel disease

Coordination Polymer Nanozymes Suppress TLR4-Mediated Inflammatory Cytokine Production

Carbon dots as nanocatalytic medicine for anti-inflammation therapy

Mn3o4 Nanozyme For Inflammatory Bowel Disease Therapy

Mn 3 O 4 nanozymes for in vivo anti-in fl ammation †

Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis

A drug-free nanozyme for mitigating oxidative stress and inflammatory bowel disease

Inhibition of Transmural Inflammation in Crohn’s Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors

Inhibition of Transmural Inflammation in Crohn's Disease by Orally Administered Tumor Necrosis Factor-Alpha Deoxyribozymes-Loaded Pyroptosis Nanoinhibitors

Versatile carbon dots with superoxide dismutase-like nanozyme activity and red fluorescence for inflammatory bowel disease therapeutics

Reactive Oxygen Species‐Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases (Adv. Healthcare Mater. 29/2023)

ZnO nanoparticles act as supportive therapy in DSS-induced ulcerative colitis in mice by maintaining gut homeostasis and activating Nrf2 signaling

Modulating Pt nanozyme by using isolated cobalt atoms to enhance catalytic activity for alleviating osteoarthritis

Superoxide Dismutase-Embedded Metal-Organic Frameworks Via Biomimetic Mineralization for the Treatment of Inflammatory Bowel Disease.

An Orally Administered CeO2@Montmorillonite Nanozyme Targets Inflammation for Inflammatory Bowel Disease Therapy

hCeO2@ Cu5.4O nanoparticle alleviates inflammatory responses by regulating the CTSB–NLRP3 signaling pathway

Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis.